Aura Biosciences (AURA) Non-Current Assets (2020 - 2026)

Aura Biosciences has reported Non-Current Assets for 7 years, with the latest figure at $19.2 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 8.19% year-over-year to $19.2 million; the trailing twelve-month figure through Mar 2026 stood at $79.2 million (down 9.28% YoY), and the FY2025 full-year result was $19.7 million, down 10.0% from the prior year.
• Non-Current Assets for Q1 2026 stood at $19.2 million, down from $19.7 million in the prior quarter.
• The five-year high for Non-Current Assets was $27.2 million in Q3 2022, with the low at $6.8 million in Q1 2022.
• Historically, Non-Current Assets has averaged $21.2 million across 5 years, with a median of $21.9 million in 2024.
• Annual changes were most pronounced in 2022 — Non-Current Assets soared 330.49% — and 2024, when it fell 15.53%.
• Aura Biosciences' Non-Current Assets stood at $27.2 million in 2022, then fell by 14.51% to $23.3 million in 2023, then dropped by 6.02% to $21.9 million in 2024, then slipped by 10.0% to $19.7 million in 2025, then decreased by 2.63% to $19.2 million in 2026.
• The last three Non-Current Assets figures came in at $19.2 million (Q1 2026), $19.7 million (Q4 2025), and $19.9 million (Q3 2025), per Business Quant data.